NANOSPHERE HEA.SCIENCES
Healthcare · EUR · F
Price
€0.001
Cap
€15,412
Earnings
—
30d Trend
-85.7%
BRAIN47 SIGNAL
Raw weighted: 54×Macro 0.99 (−1%)=53
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
Medium-term outlook is neutral — no clear directional thesis
BRAIN47'S ASSESSMENT
I rate NANOSPHERE HEA.SCIENCES at 53/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is fundamentals at 90/100. I classify this as a growth position with the strongest thesis on a medium-term horizon.
PAST PERFORMANCE
1 MONTH
-75.0%
3 MONTHS
-87.5%
12 MONTHS
—
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Medium-term outlook is neutral — no clear directional thesis. Fundamentals (90) and Momentum (83) are the primary strengths. I note that quality is the weakest area at 30/100 — this warrants monitoring. I classify this as a growth position — strong momentum combined with solid fundamentals points to capital appreciation.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.